Sanofi Pursues Sale Of Painkiller After Political Controversy
58 minutes ago · The sale of a controlling 50-percent stake in Opella to CD&R values the maker of France's leading painkiller, Doliprane, at 16 billion euros ($17.4 billion), Sanofi said.
Sanofi's potential sale of Doliprane: Impact on France's healthcare ...
3 days ago · A row has erupted in the medical community in France after Sanofi, manufacturer of popular painkiller Doliprane, announced it may sell control of its healthcare business to US investment fund CD&R. Sanofi’s consumer healthcare business, which markets Doliprane, is called Opella. It recorded sales of €5.2 billion in 2023, and employs 1,700 ...
Uproar over sale of beloved French painkiller to American company
6 days ago · This picture taken on October 23, 2023, shows boxes of Doliprane tabs in a pharmacy in Riedisheim, eastern France. SEBASTIEN BOZON / AFP The planned sale of France's best-selling medical drug to ...
Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI | Reuters
13 hours ago · The plan for Public Investment Bank (BPI) to take a 1% stake in Opella, for about 150 million euros ($162.98 million), came through a tri-party agreement between Sanofi, the French state and CD&R ...
Hands off the Doliprane: French outcry over plan to sell popular ...
6 days ago · In French pharmacies, the brand's colourful boxes often line entire shelf walls, and Doliprane comes in many doses – from 100 mg for newborn babies to 1,000 mg for adults – and in tablet ...
France seeks job guarantees from Sanofi over Doliprane painkiller ...
6 days ago · Doliprane, an over-the-counter painkiller, is France's best-selling drug and news that it could be partially sold to a foreign investor has prompted political concerns, in a first test case for ...
Sanofi Enters Exclusive Talks With CD&R for Opella Sale - U.S. News
2 hours ago · Sanofi Enters Exclusive Talks With CD&R for Opella Sale. A logo of Sanofi is seen at the Sanofi's Doliprane production site in Compiegne, France, October 17, 2024. REUTERS/Sarah Meyssonnier/ File ...
France's top-selling painkiller may be sold to the U.S. and
5 days ago · It is so ubiquitous that French people call any paracetamol product Doliprane, even when made by a different manufacturer. Sanofi, France’s biggest healthcare company and among the world’s top...
France could block sale of 'best-selling' drug if production ... - RFI
6 days ago · Doliprane is France's best-selling drug, and news that it could be sold, even in part, to a foreign investor prompted reactions from across the political spectrum.
French government stuck in Doliprane dilemma - Le Monde.fr
4 days ago · On Friday, October 11, the pharmaceutical giant announced its intention to sell 50% of Opella, its subsidiary specializing in over-the-counter products including Doliprane, to an American ...
- Some results have been removed